Kits Eyecare, the Consumer Cyclical sector company, was revisited by a Wall Street analyst yesterday. Analyst Gianluca Tucci from Haywood reiterated a Buy rating on the stock and has a C$24.00 price target.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gianluca Tucci has given his Buy rating due to a combination of factors that, in his view, the market is currently overlooking. After a roughly 50% pullback driven by currency pressures, cautious guidance, and broader risk-off sentiment, he argues that the selloff does not reflect any deterioration in the core business or its long‑term prospects.
He points to a strong operational track record, including many consecutive quarters of positive adjusted EBITDA, a growing base of more than one million active customers, and revenue already surpassing key milestones. Tucci also highlights rapid expansion in the higher-value glasses segment and KITS’s evolution into a technology-focused vision platform, suggesting the current valuation offers an attractive entry point relative to its growth trajectory.
According to TipRanks, Tucci is ranked #1926 out of 12185 analysts.
In another report released on May 7, ATB Cormark Capital Markets also maintained a Buy rating on the stock with a C$16.75 price target.